Elantas Beck

Is Elantas Beck overvalued or undervalued?

As of April 7, 2020, Elantas Beck is considered very expensive and overvalued with a PE ratio of 59.66, significantly higher than peers like Godrej Industries and Deepak Nitrite, despite a strong 3-year return of 165.28% and a year-to-date decline of 19.45%.

As of 7 April 2020, Elantas Beck's valuation grade has moved from expensive to very expensive, indicating a significant increase in perceived overvaluation. The company is currently assessed as overvalued. Key ratios include a PE ratio of 59.66, an EV to EBITDA of 51.32, and a Price to Book Value of 9.33, all of which are considerably high compared to industry standards.<BR><BR>In comparison with peers, Elantas Beck's PE ratio is notably higher than Godrej Industries, which has a PE of 46.63 and is rated as attractive, and Deepak Nitrite, which has a PE of 37.97 and is also rated very expensive. The high valuation ratios suggest that Elantas Beck is trading at a premium compared to its peers, reinforcing the conclusion of overvaluation. Despite a strong 3-year return of 165.28%, the recent performance shows a year-to-date decline of 19.45%, further highlighting the disconnect between valuation and market performance.

Who are the top shareholders of the Elantas Beck?

The top shareholders of Elantas Beck are Elantas GmbH with 75.0%, followed by Nippon Life India Trustee Ltd at 7.75%, mutual funds with 11.69%, foreign institutional investors at 0.51%, and individual investors holding 9.31%.

The top shareholders of Elantas Beck include Elantas GmbH, which holds a significant 75.0% of the shares, making it the largest promoter. The highest public shareholder is Nippon Life India Trustee Ltd, representing the Nippon India Small Cap Fund, with a holding of 7.75%. Additionally, mutual funds collectively hold 11.69% through three schemes, while foreign institutional investors (FIIs) hold 0.51% across four entities. Individual investors account for 9.31% of the shares.

Who are in the management team of Elantas Beck?

As of December 2022, the management team of Elantas Beck includes Suresh Talwar, Ranjal Laxmana Shenoy, Dhekne Vasant Nandkumar, Usha Rajeev (Independent Directors), Martin Babilas (Chairman), Stefan Genten (Alternate Director), Abhijit Tikekar (Company Secretary), Srikumar Ramakrishnan (Managing Director), and Ravindra Kumar (Director). The team features a mix of independent directors and executive leadership.

As of December 2022, the management team of Elantas Beck includes the following members:<BR><BR>1. Suresh Talwar - Independent Director<BR>2. Ranjal Laxmana Shenoy - Independent Director<BR>3. Martin Babilas - Chairman (Non-Executive)<BR>4. Stefan Genten - Alternate Director<BR>5. Abhijit Tikekar - Company Secretary & Compliance Officer<BR>6. Srikumar Ramakrishnan - Managing Director<BR>7. Dhekne Vasant Nandkumar - Independent Director<BR>8. Usha Rajeev - Independent Director<BR>9. Ravindra Kumar - Director<BR><BR>This team comprises a mix of independent directors, executive roles, and compliance leadership.

When is the next results date for Elantas Beck?

No Upcoming Board Meetings

What does Elantas Beck do?

Elantas Beck India Ltd is a mid-cap specialty chemicals company focused on manufacturing chemicals for electrical insulation and construction. As of March 2025, it reported net sales of 206 Cr and a net profit of 33 Cr, with a market cap of Rs 8,007 Cr.

Overview:<BR>Elantas Beck India Ltd is a mid-cap company operating in the specialty chemicals industry, focusing on manufacturing chemicals for electrical insulation and construction.<BR><BR>History:<BR>Incorporated on March 15, 1956, Elantas Beck India Ltd was formerly known as Beck India Limited. The latest reported quarterly results indicate net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>- Net Sales: 206 Cr (Quarterly Results - Mar 2025)<BR>- Net Profit: 33 Cr (Quarterly Results - Mar 2025)<BR>- Market cap: Rs 8,007 Cr (Mid Cap)<BR><BR>Key Metrics:<BR>- P/E: 58.00<BR>- Industry P/E: 47<BR>- Dividend Yield: 0.08%<BR>- Debt Equity: -0.61<BR>- Return on Equity: 15.63%<BR>- Price to Book: 9.06<BR><BR>Contact Details:<BR>Address: 147 Mumbai-Pune Road, Pimpri Pune Maharashtra : 411018<BR>Tel: 91-20-30610600<BR>Email: shirish.dabir@altanachemie.com<BR>Website: http://www.elantas.com/beck-india

Has Elantas Beck declared dividend?

Elantas Beck India Ltd has declared a 75% dividend, amounting to ₹7.5 per share, with an ex-date of April 23, 2025. While the company has shown significant long-term growth, recent short-term returns have been negative.

Elantas Beck India Ltd has declared a 75% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 75%<BR>- Amount per share: 7.5<BR>- Ex-date: April 23, 2025<BR><BR>Dividend Yield: 0.08%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -22.26%, the dividend return was 0.06%, resulting in a total return of -22.2%.<BR><BR>Over the past year, the price return was -8.88%, the dividend return was 0.07%, leading to a total return of -8.81%.<BR><BR>In the 2-year period, the price return was 62.03%, the dividend return was 0.20%, culminating in a total return of 62.23%.<BR><BR>For the 3-year period, the price return was 158.6%, the dividend return was 0.49%, resulting in a total return of 159.09%.<BR><BR>In the last 4 years, the price return was 183.26%, the dividend return was 0.60%, leading to a total return of 183.86%.<BR><BR>Over the past 5 years, the price return was 335.14%, the dividend return was 1.44%, resulting in a total return of 336.58%.<BR><BR>Overall, Elantas Beck has declared a substantial dividend, which, while contributing to total returns, has seen varied performance across different periods, with significant growth in the longer term despite recent declines in shorter periods.

Who are the peers of the Elantas Beck?

Elantas Beck's peers include Pidilite Inds., SRF, Gujarat Fluoroch, Deepak Nitrite, Himadri Special, Epigral, Laxmi Organic, Styrenix Perfor., and Balaji Amines. Elantas Beck has a below-average growth rate and a 1-year return of -13.49%, lower than its peers, with varying management and capital structure risks among them.

Peers: The peers of Elantas Beck are Pidilite Inds., SRF, Gujarat Fluoroch, Deepak Nitrite, Himadri Special, Epigral, Laxmi Organic, Styrenix Perfor., Balaji Amines.<BR><BR>Quality Snapshot: Excellent management risk is observed at Deepak Nitrite and Styrenix Perfor., while Good management risk is found at Pidilite Inds., SRF, Elantas Beck, Epigral, and Neogen Chemicals. Average management risk is noted at Gujarat Fluoroch, Himadri Special, Laxmi Organic, and Balaji Amines. Growth is Average at Pidilite Inds. and SRF, while Below Average growth is seen at Elantas Beck, Gujarat Fluoroch, Deepak Nitrite, Epigral, and Neogen Chemicals. Good growth is observed at Himadri Special and Styrenix Perfor., while Average growth is noted at Laxmi Organic and Balaji Amines. Excellent capital structure is seen at Pidilite Inds., SRF, Deepak Nitrite, Elantas Beck, Styrenix Perfor., and Laxmi Organic, while Good capital structure is found at Gujarat Fluoroch and Himadri Special, and Average capital structure is noted at Epigral, Balaji Amines, and Neogen Chemicals.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Epigral at 48.98%, while the lowest is Deepak Nitrite at -9.56%. Elantas Beck's 1-year return is -13.49%, which is lower than both. Additionally, the peers with negative six-month returns include Deepak Nitrite, Himadri Special, Laxmi Organic, Balaji Amines, and Neogen Chemicals.

How big is Elantas Beck?

As of 24th July, Elantas Beck India Ltd has a market capitalization of 10,597.00 Cr, with recent Net Sales of 778.06 Cr and a Net Profit of 135.53 Cr.

As of 24th July, Elantas Beck India Ltd has a market capitalization of 10,597.00 Cr, categorizing it as a Mid Cap company.<BR><BR>In the latest four quarters, the company reported Net Sales of 778.06 Cr and a Net Profit of 135.53 Cr.<BR><BR>The latest annual period for the balance sheet is December 2024, with Shareholder's Funds amounting to 867.12 Cr and Total Assets of 1,015.34 Cr.

Is Elantas Beck technically bullish or bearish?

As of 14 October 2025, Elantas Beck's technical trend has shifted to bearish with moderate strength, driven by bearish MACD, Bollinger Bands, and moving averages, despite a mildly bullish signal from Dow Theory.

As of 14 October 2025, the technical trend for Elantas Beck has changed from mildly bearish to bearish. The current technical stance is bearish with moderate strength. Key indicators driving this stance include a bearish MACD on the weekly chart, bearish Bollinger Bands on both weekly and monthly time frames, and bearish moving averages on the daily chart. The KST is also bearish on the weekly chart, while the Dow Theory shows a mildly bullish signal on the weekly but no trend on the monthly, indicating mixed signals. Overall, the bearish indicators outweigh the mildly bullish signal from Dow Theory.

How has been the historical performance of Elantas Beck?

Elantas Beck has shown consistent growth, with net sales increasing from 644.70 Cr in December 2022 to 748.51 Cr in December 2024, and profit after tax rising from 137.30 Cr to 139.56 Cr during the same period. Total assets grew to 1,015.34 Cr in December 2024, supported by an increase in shareholder's funds to 867.12 Cr.

Answer:<BR>The historical performance of Elantas Beck shows a consistent growth trend in net sales and profits over the years, with the latest figures for December 2024 indicating net sales of 748.51 Cr and a profit after tax of 139.56 Cr.<BR><BR>Breakdown:<BR>Elantas Beck has demonstrated a steady increase in net sales from 644.70 Cr in December 2022 to 748.51 Cr in December 2024. This growth is reflected in the operating profit, which rose from 131.42 Cr in December 2022 to 199.13 Cr in December 2024. The profit before tax remained relatively stable, with a slight decrease from 183.62 Cr in December 2023 to 183.45 Cr in December 2024, while profit after tax increased from 137.30 Cr to 139.56 Cr during the same period. The company's total assets also grew significantly, reaching 1,015.34 Cr in December 2024, up from 880.53 Cr in December 2023. This growth in assets is supported by an increase in shareholder's funds, which rose to 867.12 Cr in December 2024 from 731.99 Cr in December 2023. Cash flow from operating activities showed a decline from 133.00 Cr in December 2023 to 63.00 Cr in December 2024, but the overall net cash inflow improved to 136.00 Cr in December 2024, compared to a net outflow of 2.00 Cr in December 2023.

Are Elantas Beck India Ltd latest results good or bad?

Elantas Beck India Ltd's latest results show year-on-year revenue growth of 9.26% and an 8.58% increase in net profit, indicating resilience; however, a sequential revenue decline and margin compression raise concerns about operational challenges. Overall, the results are mixed, with positive annual performance but issues in recent metrics and market positioning.

Elantas Beck India Ltd's latest quarterly results present a mixed picture. On one hand, the company achieved a year-on-year revenue growth of 9.26%, which indicates a resilient demand for its products. However, there was a sequential decline in revenue of 0.62%, dropping to ₹215.20 crores from ₹216.55 crores in the previous quarter. <BR><BR>In terms of profitability, the net profit increased by 8.58% quarter-on-quarter to ₹39.37 crores, which is a positive sign. The profit after tax (PAT) margin also improved to 18.29%, up from 16.74% in the prior quarter. However, operating margins contracted to 20.90%, down from 21.79%, raising concerns about cost pressures.<BR><BR>Overall, while the year-on-year growth and net profit increase are encouraging, the sequential revenue decline and margin compression suggest that the company is facing some operational challenges. Additionally, the stock has underperformed compared to its peers in the specialty chemicals sector, which may lead to questions about its current valuation. Therefore, the results can be seen as good in terms of year-on-year performance but concerning when looking at the sequential metrics and market performance.

Should I buy, sell or hold Elantas Beck India Ltd?

Why is Elantas Beck India Ltd falling/rising?

As of 16-Mar, Elantas Beck India Ltd's stock price is Rs. 7,516.70, down 4.63% and has reached a 52-week low of Rs. 7,400. The stock has underperformed significantly, with a year-to-date decline of 21.48% compared to the Sensex's 11.40% drop.

As of 16-Mar, Elantas Beck India Ltd's stock price is falling, currently at Rs. 7,516.70, which reflects a decrease of Rs. 364.95 or 4.63%. The stock has been on a downward trend, having lost value for four consecutive days, resulting in a total decline of 11.21% during this period. Additionally, the stock reached a new 52-week low of Rs. 7,400 today, marking a significant drop of 6.11% at its intraday low.<BR><BR>In terms of performance relative to the market, Elantas Beck has underperformed its sector by 5.3% today. Over the past week, the stock has decreased by 3.68%, while its performance over the last month shows a decline of 15.60%, compared to a 9.34% drop in the Sensex. Year-to-date, the stock is down 21.48%, significantly worse than the Sensex's decline of 11.40%. Over the past year, the stock has fallen by 25.10%, contrasting sharply with the Sensex's increase of 2.27%.<BR><BR>The stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Despite a rise in investor participation, with delivery volume increasing by 50.27% against the 5-day average, the overall sentiment remains negative, contributing to the stock's decline.

Which are the latest news on Elantas Beck?

Which are the latest news on Elantas Beck?

Which are the latest news on Elantas Beck?